<VariationArchive VariationID="2946123" VariationName="NM_000112.4(SLC26A2):c.961del (p.Leu321fs)" VariationType="Deletion" Accession="VCV002946123" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3098116" VariationID="2946123">
      <GeneList>
        <Gene Symbol="SLC26A2" FullName="solute carrier family 26 member 2" GeneID="1836" HGNC_ID="HGNC:10994" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="149960758" stop="149987400" display_start="149960758" display_stop="149987400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="149340299" stop="149366962" display_start="149340299" display_stop="149366962" Strand="+" />
          </Location>
          <OMIM>606718</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000112.4(SLC26A2):c.961del (p.Leu321fs)</Name>
      <CanonicalSPDI>NC_000005.10:149980553:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="149980554" stop="149980554" display_start="149980554" display_stop="149980554" variantLength="1" positionVCF="149980553" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="149360117" stop="149360117" display_start="149360117" display_stop="149360117" variantLength="1" positionVCF="149360116" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L321fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.149980554del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.149980554del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.149360117del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.149360117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007147.2" sequenceAccession="NG_007147" sequenceVersion="2" change="g.21672del">
            <Expression>NG_007147.2:g.21672del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000112.4" sequenceAccession="NM_000112" sequenceVersion="4" change="c.961del" MANESelect="true">
            <Expression>NM_000112.4:c.961del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000103.2" sequenceAccession="NP_000103" sequenceVersion="2" change="p.Leu321fs">
            <Expression>NP_000103.2:p.Leu321fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_684" sequenceAccession="LRG_684">
            <Expression>LRG_684:g.21672del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_684t1" sequenceAccession="LRG_684t1">
            <Expression>LRG_684t1:c.961del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_684p1" sequenceAccession="LRG_684p1" change="p.Leu321Serfs">
            <Expression>LRG_684p1:p.Leu321Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000112.4(SLC26A2):c.961del (p.Leu321fs) AND multiple conditions" Accession="RCV003806409" Version="1">
        <ClassifiedConditionList TraitSetID="12100">
          <ClassifiedCondition DB="MedGen" ID="C0265274">Achondrogenesis, type IB</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1850554">Atelosteogenesis type II</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0220726">Diastrophic dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847593">Multiple epiphyseal dysplasia type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11448940</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15294877</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21077204</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12100" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="64" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Achondrogenesis Fraccaro type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Achondrogenesis, type IB</ElementValue>
                <XRef ID="Achondrogenesis+Type+1B/109" DB="Genetic Alliance" />
                <XRef ID="14870002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACG1B</ElementValue>
                <XRef Type="MIM" ID="600972" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of achondrogenesis type 1B (ACG1B) include extremely short limbs with short fingers and toes, hypoplasia of the thorax, protuberant abdomen, and hydropic fetal appearance caused by the abundance of soft tissue relative to the short skeleton. The face is flat, the neck is short, and the soft tissue of the neck may be thickened. Death occurs prenatally or shortly after birth.</Attribute>
                <XRef ID="NBK1516" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="460" />
                <XRef ID="460" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301689</ID>
                <ID Source="BookShelf">NBK1516</ID>
              </Citation>
              <XRef ID="932" DB="Orphanet" />
              <XRef ID="93298" DB="Orphanet" />
              <XRef ID="C0265274" DB="MedGen" />
              <XRef ID="MONDO:0010966" DB="MONDO" />
              <XRef Type="MIM" ID="600972" DB="OMIM" />
            </Trait>
            <Trait ID="558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEONATAL OSSEOUS DYSPLASIA I</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neonatal osseous dysplasia 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atelosteogenesis type 2</ElementValue>
                <XRef ID="Atelosteogenesis+Type+2/641" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Atelosteogenesis type II</ElementValue>
                <XRef ID="MONDO:0009727" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AO2</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AOII</ElementValue>
                <XRef Type="MIM" ID="256050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Clinical features of atelosteogenesis type 2 (AO2) include rhizomelic limb shortening with normal-sized skull, hitchhiker thumbs, small chest, protuberant abdomen, cleft palate, and distinctive facial features (midface retrusion, depressed nasal bridge, epicanthus, micrognathia). Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. AO2 is usually lethal at birth or shortly thereafter due to pulmonary hypoplasia and tracheobronchomalacia. However, it exists in a continuous phenotypic spectrum with diastrophic dysplasia, and long-term survivors have been reported.</Attribute>
                <XRef ID="NBK1317" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8329" />
                <XRef ID="8329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301493</ID>
                <ID Source="BookShelf">NBK1317</ID>
              </Citation>
              <XRef ID="56304" DB="Orphanet" />
              <XRef ID="C1850554" DB="MedGen" />
              <XRef ID="MONDO:0009727" DB="MONDO" />
              <XRef Type="MIM" ID="256050" DB="OMIM" />
            </Trait>
            <Trait ID="1977" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diastrophic dysplasia</ElementValue>
                <XRef ID="Diastrophic+Dysplasia/2261" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009107" DB="MONDO" />
                <XRef ID="58561002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diastrophic dwarfism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DTD</ElementValue>
                <XRef Type="MIM" ID="222600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diastrophic dysplasia (DTD) is characterized by limb shortening, normal-sized head, hitchhiker thumbs, spinal deformities (scoliosis, exaggerated lumbar lordosis, cervical kyphosis), and contractures of the large joints with deformities and early-onset osteoarthritis. Other typical findings are ulnar deviation of the fingers, gap between the first and second toes, and clubfoot. On occasion, the disease can be lethal at birth, but most affected individuals survive the neonatal period and develop physical limitations with normal intelligence.</Attribute>
                <XRef ID="NBK1350" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6275" />
                <XRef ID="6275" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301524</ID>
                <ID Source="BookShelf">NBK1350</ID>
              </Citation>
              <XRef ID="628" DB="Orphanet" />
              <XRef ID="C0220726" DB="MedGen" />
              <XRef ID="MONDO:0009107" DB="MONDO" />
              <XRef Type="MIM" ID="222600" DB="OMIM" />
            </Trait>
            <Trait ID="1181" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with clubfoot</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with double-layered patella</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple epiphyseal dysplasia with bilayered patellae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple Epiphyseal Dysplasia, Recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple epiphyseal dysplasia type 4</ElementValue>
                <XRef ID="MONDO:0009189" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDM4</ElementValue>
                <XRef Type="MIM" ID="226900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Recessive multiple epiphyseal dysplasia (EDM4/rMED) is characterized by joint pain (usually in the hips or knees); malformations of hands, feet, and knees; and scoliosis. Approximately 50% of affected individuals have an abnormal finding at birth, e.g., clubfoot, clinodactyly, or (rarely) cystic ear swelling. Onset of articular pain is variable but usually occurs in late childhood. Stature is usually within the normal range prior to puberty; in adulthood, stature is only slightly diminished and ranges from 150 to 180 cm. Functional disability is mild.</Attribute>
                <XRef ID="NBK1306" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9793" />
                <XRef ID="9793" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301483</ID>
                <ID Source="BookShelf">NBK1306</ID>
              </Citation>
              <XRef ID="93307" DB="Orphanet" />
              <XRef ID="C1847593" DB="MedGen" />
              <XRef ID="MONDO:0009189" DB="MONDO" />
              <XRef Type="MIM" ID="226900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8549379" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="20181656|MedGen:C1850554;C1847593;C0265274;C0220726" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004591332" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11448940</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15294877</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21077204</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with SLC26A2-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the SLC26A2 protein in which other variant(s) (p.Ala715Val) have been determined to be pathogenic (PMID: 11448940, 15294877, 21077204). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu321Serfs*21) in the SLC26A2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 419 amino acid(s) of the SLC26A2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC26A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.149360117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850554" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1847593" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265274" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0220726" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8549379" TraitType="Disease" MappingType="XRef" MappingValue="C0265274" MappingRef="MedGen">
        <MedGen CUI="C0265274" Name="Achondrogenesis, type IB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8549379" TraitType="Disease" MappingType="XRef" MappingValue="C1847593" MappingRef="MedGen">
        <MedGen CUI="C1847593" Name="Multiple epiphyseal dysplasia type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8549379" TraitType="Disease" MappingType="XRef" MappingValue="C1850554" MappingRef="MedGen">
        <MedGen CUI="C1850554" Name="Atelosteogenesis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8549379" TraitType="Disease" MappingType="XRef" MappingValue="C0220726" MappingRef="MedGen">
        <MedGen CUI="C0220726" Name="Diastrophic dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

